BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 28424829)

  • 21. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
    Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
    Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric MR Imaging for Detection and Locoregional Staging of Prostate Cancer.
    Bittencourt LK; de Hollanda ES; de Oliveira RV
    Top Magn Reson Imaging; 2016 Jun; 25(3):109-17. PubMed ID: 27187165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
    Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
    BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.
    Fenstermaker M; Mendhiratta N; Bjurlin MA; Meng X; Rosenkrantz AB; Huang R; Deng FM; Zhou M; Huang WC; Lepor H; Taneja SS
    Urology; 2017 Jan; 99():174-179. PubMed ID: 27562202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer.
    Hoffmann MA; Taymoorian K; Ruf C; Gerhards A; Leyendecker K; Stein T; Jakobs FM; Schreckenberger M
    Anticancer Res; 2017 Dec; 37(12):6871-6877. PubMed ID: 29187467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of significant prostate cancer with magnetic resonance targeted biopsies--should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care?
    Delongchamps NB; Lefèvre A; Bouazza N; Beuvon F; Legman P; Cornud F
    J Urol; 2015 Apr; 193(4):1198-204. PubMed ID: 25451824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic Resonance-Guided Prostate Biopsy.
    Dianat SS; Carter HB; Macura KJ
    Magn Reson Imaging Clin N Am; 2015 Nov; 23(4):621-31. PubMed ID: 26499279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiparametric MRI fusion-guided biopsy for the diagnosis of prostate cancer.
    Kesch C; Schütz V; Dieffenbacher S; Bonekamp D; Hadaschik BA; Hohenfellner M; Radtke JP
    Curr Opin Urol; 2018 Mar; 28(2):172-177. PubMed ID: 29083999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.
    Peltier A; Aoun F; Albisinni S; Marcelis Q; Ledinh D; Paesmans M; Lemort M; van Velthoven R
    Scand J Urol; 2016 Jun; 50(3):144-8. PubMed ID: 26754860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure.
    Cash H; Günzel K; Maxeiner A; Stephan C; Fischer T; Durmus T; Miller K; Asbach P; Haas M; Kempkensteffen C
    BJU Int; 2016 Jul; 118(1):35-43. PubMed ID: 26384851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of 3-Tesla multiparametric magnetic resonance imaging and targeted biopsy for improved risk stratification in patients considered for active surveillance.
    Pessoa RR; Viana PC; Mattedi RL; Guglielmetti GB; Cordeiro MD; Coelho RF; Nahas WC; Srougi M
    BJU Int; 2017 Apr; 119(4):535-542. PubMed ID: 27500389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MR imaging-guided prostate biopsy techniques.
    Verma S; Bhavsar AS; Donovan J
    Magn Reson Imaging Clin N Am; 2014 May; 22(2):135-44, v. PubMed ID: 24792674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-based Patient Selection for Magnetic Resonance Imaging-targeted Prostate Biopsy after Negative Transrectal Ultrasound-guided Random Biopsy Avoids Unnecessary Magnetic Resonance Imaging Scans.
    Alberts AR; Schoots IG; Bokhorst LP; van Leenders GJ; Bangma CH; Roobol MJ
    Eur Urol; 2016 Jun; 69(6):1129-34. PubMed ID: 26651990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of the Prostate-An Update.
    Das CJ; Razik A; Sharma S
    Semin Roentgenol; 2018 Jul; 53(3):219-226. PubMed ID: 30031415
    [No Abstract]   [Full Text] [Related]  

  • 35. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
    Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
    Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiparametric prostate MRI: focus on T2-weighted imaging and role in staging of prostate cancer.
    Gupta RT; Spilseth B; Patel N; Brown AF; Yu J
    Abdom Radiol (NY); 2016 May; 41(5):831-43. PubMed ID: 27193786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
    Junker D; Schäfer G; Heidegger I; Bektic J; Ladurner M; Jaschke W; Aigner F
    Urol Int; 2015; 94(3):313-8. PubMed ID: 25591786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnosis and Pathologic Reporting of Prostate Cancer in the Era of MRI-Targeted Prostate Biopsy.
    Coiner BL; Rais-Bahrami S; Gordetsky JB
    Surg Pathol Clin; 2022 Dec; 15(4):609-616. PubMed ID: 36344178
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of a five-point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image-fusion targeted biopsy of the prostate.
    Shin T; Smyth TB; Ukimura O; Ahmadi N; de Castro Abreu AL; Ohe C; Oishi M; Mimata H; Gill IS
    BJU Int; 2018 Jan; 121(1):77-83. PubMed ID: 28749070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparametric (mp) MRI of prostate cancer.
    Kumar V; Bora GS; Kumar R; Jagannathan NR
    Prog Nucl Magn Reson Spectrosc; 2018 Apr; 105():23-40. PubMed ID: 29548365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.